http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94c00f5c46c2f40b8576de9c580a107a
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Ziegler |
| name | Regina G. Ziegler Regina G Ziegler |
| given-name | Regina G Regina G. |
| organization-name | Laboratory of Proteomics and Analytical Technologies, SAIC—Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland 21702, National Cancer Institute at Frederick, Frederick, Maryland 21702, Laser Capture Microdissection Core Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20877, and Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892 1Epidemiology and Biostatistics Program; 2Biostatistics Branch, and 3Clinical Genetics Branch, Human Genetics Program; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 4Laboratory of Proteomics and Analytical Technologies, Advanced Technology Program, Science Applications International Corporation-Frederick, Inc., 5Laboratory of Comparative Carcinogenesis, National Cancer Institute at Frederick, Frederick, Maryland; and 6Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, California Authors' Affiliations: 1Channing Laboratory, Department of Medicine, and 2Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School; Departments of 3Epidemiology, 4Biostatistics, and 5Nutrition, Harvard School of Public Health, Boston, Massachusetts; 6Laboratory of Proteomics and Analytical Technologies, Advanced Technology Program, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland; 7Division of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, Massachusetts; and 8Laboratory of Comparative Carcinogenesis, Center for Cancer Research, and 9Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. Authors' Affiliations: 1Genetic Epidemiology Branch, 2Biostatistics Branch, and 3Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda; 4Laboratory of Proteomics and Analytical Technologies, Advanced Technology Program, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland; 5Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 6Department of Epidemiology, Harvard School of Public Health, Boston; and 7Division of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, Massachusetts 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland; 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 6Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland. National Cancer Institute 1Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics, National Cancer Institute National Institutes of Health Bethesda Maryland Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA, Authors' Affiliations: 1Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 2Harvard School of Public Health; 3University of Massachusetts, Amherst; 4Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda; and 5SAIC, Inc., National Cancer Institute at Frederick, Frederick, Maryland 2Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; Authors' Affiliations: 1Program in Molecular and Genetic Epidemiology; Departments of 2Epidemiology, and 3Nutrition, Harvard School of Public Health, Boston, Massachusetts; 4Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; 5Genomic Epidemiology Group, 6Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 7Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom; 8Cancer Epidemiology and Genetics, and 9Cancer Prevention, National Cancer Institute, Bethesda, Maryland; 10Department of Epidemiology, Deutsches Institut für Ernährungsforschung, Potsdam-Rehbrücke, Germany; 11National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; Divisions of 12Preventive Medicine and 13Aging, Department of Medicine, Brigham and Women's Hospital, and 14Harvard Medical School, Boston, Massachusetts; 15Department of Ambulatory Care and Prevention, 16Division for Research and Educati Division of Cancer Epidemiology and Genetics National Cancer Institute, NIH Rockville MD Division of Cancer Epidemiology and Genetics , National Cancer Institute, National Institutes of Health, Bethesda, MD 20850 , USA 1Cancer Epidemiology and Genetics and Divisions of Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD Authors' Affiliations: 1Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 2Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts; and 3Core Genotyping Facility at the Advanced Technology Center, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, Maryland 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 1Cancer Epidemiology and Genetics, Divisions of Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda MD Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland 21702, Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, Laboratory of Comparative Carcinogenesis, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland 21702, and Basic Research Program, SAIC-Frederick, Inc., National Cancer Institute at Frederick,... 4Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 1Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York. 10Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. 1Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; Departments of 2Biostatistics and 3Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 4Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; and 5Laboratory of Proteomics and Analytical Technologies, Advanced Technology Program, Science Applications International Corporation-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland Authors' Affiliations: 1Cancer Prevention Fellowship Program, Center for Cancer Training, 2Epidemiology and Biostatistics Program, 3Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, and 4Laboratory of Comparative Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland and 5Laboratory of Proteomics and Analytical Technologies, Advanced Technology Program, SAIC-Frederick, Inc., Frederick, Maryland Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland 21702, Laboratory of Comparative Carcinogenesis, Center for Cancer Research, NCI-Frederick, Frederick, Maryland 21702, and Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892 Division of Cancer Epidemiology and Genetics National Cancer Institute, National Institutes of Health Rockville MD U.S.A. Divisions of 1Cancer Epidemiology and Genetics and 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland. Authors' Affiliations: Department of 1Nutrition, 2Epidemiology, and 3Biostatistics, Harvard School of Public Health; 4Channing Division of Network Medicine and 5Divisions of Preventive Medicine and Aging, Department of Medicine, Brigham and Women's Hospital; 6Department of Ambulatory Care and Prevention, Harvard Medical School, Boston, Massachusetts; 7Division of Cancer Epidemiology and 8Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany; 9Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville; 10Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda; 11Core Genotyping Facility, Frederick National Laboratory for Cancer Research, Gaithersburg, Maryland; 12Institut National de la Santé et de la Recherche Medicale (INSERM), Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy; 13Paris South University, Villejuif; 14International Agency for Research on Cancer (IARC), Lyon, France; 15Epidemiolog Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland - USA 16Division of Cancer Epidemiology and Genetics, National Cancer Institute, U.S. NIH, Bethesda, Maryland. 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland. Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., Laboratory of Comparative Carcinogenesis, Center for Cancer Research, and Basic Research Program, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland 21702, and Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 2Department of Epidemiology and Public Health, Yale School of Public Health, New Haven, Connecticut; 3Information Management Services, Inc., Rockville, Maryland; 4AstraZeneca, Wilmington, Delaware (formerly Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland); 5Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; 6Center for Human Genetics, Marshfield Clinic Research Foundation, Marshfield, Wisconsin; and 7Pacific Health Research Institute, Honolulu, Hawaii 1Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland and Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; Departments of 2Epidemiology and 3Nutrition, Harvard School of Public Health; Divisions of 4Preventive Medicine, 5Aging, and 6Cardiovascular Disease, 7Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 8VA Boston Healthcare System, Boston, Massachusetts; 9Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 10Epidemiology Research Program, American Cancer Society, Atlanta, Georgia; 11Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany; 12Department of Biology, University of Pisa, Pisa; 13Cancer Research and Prevention Institute—ISPO, Florence, Italy; 14Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; 15National Institute for Public Hea Division of Cancer Epidemiology and Genetics , Department of Health and Human Services, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD 20892, United States Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland 21702, Mettler-Toledo, Newark, Delaware 19702, and Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892 Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Division of Cancer Epidemiology and Genetics National Cancer Institute, Rockville Maryland United States of America International Agency for Research on Cancer Lyon France 3Cancer Epidemiology and Genetics and Division of Cancer Epidemiology and Genetics National Cancer Institute, NIH Bethesda MD Division of Cancer Epidemiology and Genetics National Cancer Institute, NIH, DHHS Bethesda MD Authors' Affiliations: 1Department of Epidemiology, Mailman School of Public Health, Columbia University, New York; Departments of 2Epidemiology, 3Biostatistics, and 4Nutrition, Harvard School of Public Health; 5Division of Medical Oncology, Dana-Farber Cancer Institute; 6Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 7Division of Epidemiology and Community Health, School of Public Health, and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota; 8Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland; 9Department of Surgery and Centre for Clinical Research, Central Hospital, Vasteras, Sweden; 10Division of Cancer Etiology, Department of Population Science, Beckman Research Institute and City of Hope National Medical Center, Duarte, California; 11Department of Epidemiology, School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, the N Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Bethesda, Maryland 15Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland; Epidemiology and Biostatistics Program (R.G.Z.), Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892 4Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; |
Incoming Links
Showing number of triples: 1 to 227 of 227.